INTECH Investment Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Sell
11,935
-606
-5% -$15.4K ﹤0.01% 1562
2026
Q1
$314K Sell
12,541
-7,789
-38% -$184K ﹤0.01% 1558
2025
Q4
$535K Buy
20,330
+3,348
+20% +$73K ﹤0.01% 1480
2025
Q3
$290K Sell
16,982
-6,181
-27% -$88.5K ﹤0.01% 1844
2025
Q2
$291K Sell
23,163
-17,100
-42% -$204K ﹤0.01% 1881
2025
Q1
$480K Buy
40,263
+6,405
+19% +$87.3K ﹤0.01% 1638
2024
Q4
$496K Buy
33,858
+12,698
+60% +$178K ﹤0.01% 1570
2024
Q3
$266K Buy
+21,160
New +$230K ﹤0.01% 1582

Other funds holding ZYME

INTECH Investment Management's ZYME Position: Q2 2026 in Review

INTECH Investment Management reduced its Zymeworks (ZYME) stake by 4.8% in Q2 2026, selling an estimated $15.4K and leaving 11,935 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1562.

INTECH Investment Management first reported a position in ZYME in Q3 2024 and has held it in 8 quarters since. The position peaked at $535K in Q4 2025. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • INTECH Investment Management held 11,935 shares of Zymeworks worth $312K as of Q2 2026.
  • INTECH Investment Management sold 606 Zymeworks shares in Q2 2026, an estimated $15.4K.
  • Zymeworks made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1562 holding.
  • INTECH Investment Management first reported a position in Zymeworks in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Zymeworks position peaked at $535K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.